IDRI Announces Appointment of Dr. Karen Auditore-Hargreaves as SVP, Scientif... ( Two new Directors join the Board of t...)

IDRI Announces Appointment of Dr. Karen Auditore-Hargreaves as SVP, Scientific Affairs

Date:3/5/2009

Two new Directors join the Board of the growing global health organization

SEATTLE, March 5 /PRNewswire-USNewswire/ -- IDRI (Infectious Disease Research Institute) announced today that Dr. Karen Auditore-Hargreaves has joined IDRI as Senior Vice President (SVP) Scientific Affairs to assist the organization in the execution of its research and development programs. Dr. Auditore-Hargreaves has a proven track record in scientific management and has held senior leadership positions with leading biotech companies.

"I am delighted to welcome Karen Auditore-Hargreaves as a new member of IDRI's management team," said Curt Malloy, SVP Operations and General Counsel at IDRI. "Her appointment and her broad biotech experience signify our commitment to building a strong organization that delivers on its scientific objectives."

Karen Auditore-Hargreaves joins IDRI after 3 years as Chief Executive Officer and President of cancer vaccine company ODC Therapy, in Dallas, Texas. Prior to that, she served for 6 years as President and Chief Operating Officer of NeoRx Corporation, in Seattle, Washington, (an organization currently doing business as Poniard Pharmaceuticals). Poniard is a publicly traded biotech company developing small-molecule drugs and targeted biologics for cancer.

"Her background in drug development, along with her deep understanding of the immune system, are an exciting fit with IDRI's three-pronged mission to prevent, detect and treat infectious diseases of poverty," added Curt Malloy.

Before joining NeoRx Corporation, Dr. Hargreaves held senior research management positions with CellPro, Oculon Corporation, PATH and Genetic Systems Corporation. Dr. Hargreaves holds a PhD in Genetics from the University of California, Davis, and received her post doctoral training at the Massachusetts Institute of Technology Center for Cancer Research.

Dr. Steven R
'/>"/>

0

GOOD

Page: 1 2 3
Related medicine news :

1. Kensey Nash Announces Appointment of Chief Financial Officer
2. HMS Holdings Corp. Announces Executive Promotions
3. Solta Medical, Inc. Announces State-of-the-Art Aesthetic Center
4. Aesthera Announces Breakthrough Innovations at 2009 American Academy of Dermatology (AAD) Meeting
5. Medifast, Inc. Announces Appointment of Two Additional Independent Board Members
6. CorMatrix Cardiovascular Announces First European Implants of CorMatrix(R) ECM Technology(TM)
7. SXC Health solutions announces strong fourth quarter and year end financial results
8. Stemedica Announces the Appointment of Carl Bullen as Director of Manufacturing
9. PharmaNet Development Group Announces Flexible Staffing Business
10. Weight Watchers Announces Fourth Quarter and Full Year 2008 Results
11. Pharmos Corporation Announces Modification to Dextofisopam Trial Size, Objectives Can Still Be Achieved

Post Your Comments:

IDRI Announces Appointment of Dr. Karen Auditore-Hargreaves as SVP, Scientif...( Two new Directors join the Board of t...),Health